Literature DB >> 10880555

Role of diabetes mellitus in the etiology of hepatocellular carcinoma.

P Lagiou1, H Kuper, S O Stuver, A Tzonou, D Trichopoulos, H O Adami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10880555     DOI： 10.1093/jnci/92.13.1096

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  37 in total

Review 1.  NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Authors:  Elisabetta Bugianesi; Ester Vanni; Giulio Marchesini
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

2.  Risk of cancer in a large cohort of U.S. veterans with diabetes.

Authors:  Elizabeth A Atchison; Gloria Gridley; J Daniel Carreon; Michael F Leitzmann; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

3.  Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.

Authors:  Quan Zhang; Yan Li; Tingting Liang; Xuemian Lu; Xingkai Liu; Chi Zhang; Xin Jiang; Robert C Martin; Mingliang Cheng; Lu Cai
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 4.  Hepatocellular carcinoma and non-alcoholic fatty liver disease.

Authors:  Pegah Golabi; Logan Rhea; Linda Henry; Zobair M Younossi
Journal:  Hepatol Int       Date:  2019-11-07       Impact factor: 6.047

Review 5.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

6.  Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection.

Authors:  Kumar K Singh; Subrat K Panda; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

7.  Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.

Authors:  Hiroshi Abe; Yuta Aida; Haruya Ishiguro; Kai Yoshizawa; Tamihiro Miyazaki; Munenori Itagaki; Satoshi Sutoh; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 8.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.

Authors:  Yosui Tamaki; Yukiomi Nakade; Taeko Yamauchi; Yuichi Makino; Shiro Yokohama; Mitsuyoshi Okada; Kazunobu Aso; Hiroyuki Kanamori; Tomohiko Ohashi; Ken Sato; Haruhisa Nakao; Masakazu Haneda; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2012-08-14       Impact factor: 7.527

10.  HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.

Authors:  Rafael Guerrero-Preston; Abby Siegel; John Renz; David Vlahov; Alfred Neugut
Journal:  J Community Health       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.